Open AccessTestosterone Replacement Therapy and Cardiovascular Events
Author(s) -
Alp Burak Çatakoğlu,
Muammer Kendirci
Publication year - 2017
Publication title -
türk kardiyoloji derneği arşivi
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.2
H-Index - 24
ISSN - 1016-5169
DOI - 10.5543/tkda.2017.00531
Subject(s) - testosterone (patch) , testosterone replacement , medicine , disease , adverse effect , cardiovascular health , obesity , medical prescription , endocrinology , intensive care medicine , androgen , pharmacology , hormone
A low testosterone level and hypogonadism are associated with cardiovascular disease. Aging, chronic health problems, and obesity are all associated with a low testosterone level as well as the presence and severity of cardiovascular disease. Testosterone is increasingly prescribed for patients with clinical hypogonadism and a low testosterone level. The information we have is still contradictory regarding testosterone replacement therapy (TRT) and its association with adverse cardiovascular events. Older patients and patients who are susceptible to cardiovascular diseases could be at risk with a testosterone prescription. This is a review of the literature to discuss the cardiovascular safety of TRT.